微创医疗

0853.HK

Wind Industry: 医疗保健 > 医疗设备与服务 > 医疗保健设备与用品 > 医疗保健设备

公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括“L-REBOA”主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。

ESG Score Industry Ranking:
10 / 151 (医疗保健设备与用品)

ESG Rating Distribution(医疗保健设备与用品)

0.66%

AAA

3.31%

15.23%

21.19%

BBB

49.67%

7.95%

CCC

Trend of Rating

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：7.72Updated on 2026-10-29

07.7210

Management & Practices Score：4.82Updated on 2026-10-27

04.827

Controversies Score：2.90Updated on 2026-10-29

02.903

ESG Score Comparison

Indicator	Company Score	Industry Average	Weight
Environmental	6.88	2.78	5.84%
Social	7.64	3.82	65.37%
Governance	5.17	5.86	28.77%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB

More Details

Peer Comparison(151 companies in the industry) ?

Ranking	Code	Security Name	ESG Rating	ESG Score	Controversies Score	Management & Practices Score	Environmental	Social	Governance
1	688139.SH	海尔生物	AAA	8.91	2.98	5.93	8.20	8.84	7.69
2	002223.SZ	鱼跃医疗	AA	8.44	2.97	5.47	7.99	7.85	7.72
3	300760.SZ	迈瑞医疗	AA	8.41	2.99	5.42	6.67	7.34	8.87
4	300888.SZ	稳健医疗	AA	8.37	3.00	5.38	7.76	7.52	8.03
5	688029.SH	南微医学	AA	8.09	2.99	5.10	6.96	7.48	6.88
6	300298.SZ	三诺生物	AA	7.90	2.98	4.93	5.48	6.97	7.51
7	605369.SH	拱东医疗	A	7.85	2.97	4.88	4.37	7.00	7.42
8	300981.SZ	中红医疗	A	7.77	2.97	4.80	2.82	6.96	7.44
9	300832.SZ	新产业	A	7.75	2.88	4.87	4.67	6.99	7.35
10	0853.HK	微创医疗	A	7.72	2.90	4.82	6.88	7.64	5.17